• Needham & Company LLC Reaffirms Hold Rating for Fate Therapeutics (NASDAQ:FATE)

    Source: Buzz FX / 19 Nov 2024 08:36:09   America/New_York


    Needham & Company LLC Reaffirms Hold Rating for Fate Therapeutics (NASDAQ:FATE) Written by MarketBeat November 19, 2024 Share Link copied to clipboard. Fate Therapeutics ( NASDAQ:FATE - Get Free Report ) 's stock had its "hold" rating reaff
    Read more...
Share on,